Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients. - Wikidata - awgldk - TriplyDB

Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients.

Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients.

http://www.wikidata.org/entity/Q35072103

about

Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls.Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population.Epidemiology of ischemic heart disease in HIV.Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy.Coronary Artery Disease in HIV-Infected Patients: Downside of Living Longer.Heart failure in patients with human immunodeficiency virus infection: Epidemiology and management disparities.Graying of the HIV epidemic: a challenge for inpatient medicine providers.Presence, Characteristics, and Prognostic Associations of Carotid Plaque Among People Living With HIV.

P2860

Q33853259-328C3683-96EC-42FD-B63A-7E7D570375DE Q37225786-4BD402B7-8D4D-4616-89CB-18F398DC9175 Q38629009-86A7F03C-19FD-4F04-A926-999608BD7E52 Q38746270-71635698-4E10-4B85-A9FE-B5EAA02C2513 Q39165028-0C2DB930-C40F-40B2-BC95-721EC2C19F21 Q40656708-26DA878E-0D54-4ED0-B863-A48DC232FBF6 Q40876796-91CB25E8-78D5-4C02-84AE-C204E5BDB137 Q47818281-5378B85D-9A52-4E23-9311-FFA35076523A

P2860

Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients.

http://www.wikidata.org/entity/Q35072103

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Aspirin Use for Primary and Se ...... d and HIV-Uninfected Patients.

@ast

Aspirin Use for Primary and Se ...... d and HIV-Uninfected Patients.

@en

type

label

Aspirin Use for Primary and Se ...... d and HIV-Uninfected Patients.

@ast

Aspirin Use for Primary and Se ...... d and HIV-Uninfected Patients.

@en

prefLabel

Aspirin Use for Primary and Se ...... d and HIV-Uninfected Patients.

@ast

Aspirin Use for Primary and Se ...... d and HIV-Uninfected Patients.

@en

P1433

Q35072103-8968F0D7-2B8F-46A4-9D75-9C8BD4283396

P1476

Q35072103-4195990D-D81F-4769-BA62-972DAA349D08

P2093

Q35072103-4C251362-7741-410C-8A1E-F80954E45716

Q35072103-7C8255F8-0C43-47B7-B051-C40813B7EADD

Q35072103-A0FF429D-D077-47C5-9FE9-461605172A3F

Q35072103-A5C9EDAB-7F00-4EF8-A267-C1F2B7AFB9DF

P2860

Q35072103-07738752-978E-43E4-B643-908AAF304AAE

Q35072103-0C1069A6-F151-499F-BD61-4D80E5F93BC8

Q35072103-1A04296E-C05A-4ECE-BD3E-497AE43716BE

Q35072103-1B4B6DCB-E196-4012-BA56-733CC26B83C1

Q35072103-1D8EB60C-B881-4AF0-9064-80EB80B4422A

Q35072103-1EE89BF9-EEB9-4E5E-B4E5-878204417FBE

Q35072103-30E790C4-3960-4CCA-A084-85480277DE76

Q35072103-37D8CA26-56C2-4DA4-8601-C139C6BC643A

Q35072103-3F47D42F-6DA9-4669-9EE6-0B40AC98D1AD

Q35072103-48707BD1-D892-4716-86B5-572F95771F83

P304

Q35072103-6549398D-2D25-4D6E-BCDB-91589E0D4A5D

P31

Q35072103-CD1D66F6-FE8B-4CBB-A245-5E106BAFB9F5

P356

Q35072103-943B0940-A382-40E6-8253-CD3F2BFF9A91

P433

Q35072103-4745DF15-6DD9-4A98-AA64-F18CAD7636C2

P478

Q35072103-0FACAC18-D9FA-4D06-9027-D7BB64C7E7BB

P50

Q35072103-B13F2D22-1E3A-40A9-9DCD-DFE89C4517E7

P577

Q35072103-00CC5117-B451-4BE5-9166-87D27D796F9F

P5875

Q35072103-626C58F9-009D-45C3-A13C-23D7937BB8F3

P698

Q35072103-15DEEC50-88D7-4DBC-8D18-A32DC130BDD1

P921

Q35072103-076F16A9-936C-4E92-B0C9-74B80DDE9F68

P932

Q35072103-C37B72A5-45E9-4AED-9BFB-3DA4BFEB5D41

P356

P1433

Open forum infectious diseases

P1476

Aspirin Use for Primary and Se ...... d and HIV-Uninfected Patients.

@en

P2093

Steven K Grinspoon

http://www.w3.org/2001/XMLSchema#string

Sujit Suchindran

http://www.w3.org/2001/XMLSchema#string

Susan Regan

http://www.w3.org/2001/XMLSchema#string

Virginia A Triant

http://www.w3.org/2001/XMLSchema#string

P2860

Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.

HIV infection and the risk of acute myocardial infarction.

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Final report on the aspirin component of the ongoing Physicians' Health Study

CD4+ count-guided interruption of antiretroviral treatment

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

Extracting principal diagnosis, co-morbidity and smoking status for asthma research: evaluation of a natural language processing system.

P304

ofu076

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/OFID/OFU076

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273153202

http://www.w3.org/2001/XMLSchema#string

P698

25734156

http://www.w3.org/2001/XMLSchema#string

P921

prevention of HIV/AIDS

P932

4324233

http://www.w3.org/2001/XMLSchema#string